Healthy Skepticism Library item: 6605

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

MaLAM Letter follow up—Parke-Davis’ promotion for Ponstan (mefenamic acid)
MaLAM International News 1995 Nov; 13:(11):2

Abstract:

Parke-Davis has not provided satisfactory clinical evidence to back up its claims about Ponstan in children. Furthermore the company refuses to provide MaLAM with information about it quality assurance for promotional activities.

Keywords:
*analysis/Pakistan/developing countries/Ponstan/antipyretics/Parke-Davis/children/company responses/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES